Industry News
CMS Could Eliminate Pharmacy Remote Patient Monitoring (RPM) Revenue in 2027. Imagine waking up on January 1 and discovering that your pharmacy remote patient monitoring program is no longer billable—not because your outcomes were poor, not because your patients weren’t benefiting, and not because you did anything wrong… …but simply because you weren’t on someone […]
The FDA Peptide Meeting: What It Really Means
By Dr. Lisa Faast | | Industry News
Category 1 Peptides: What FDA’s Meeting Means for Pharmacies Category 1 peptides are back in the spotlight as the FDA’s Pharmacy Compounding Advisory Committee (PCAC) meets July 23–24 to review seven peptides for potential inclusion on the FDA’s Category 1 list, including BPC-157, KPV, TB-500, MOTS-c, Semax, Epitalon, and Emideltide (DSIP). A second meeting is […]
FDA Peptides: 7 Opportunities Pharmacies Should Watch
By Dr. Lisa Faast | | Industry News
7 FDA Peptides That Could Create Huge Opportunities for Independent Pharmacies If you’ve noticed FDA peptides suddenly showing up everywhere lately, you’re not imagining it. Patients are asking about them. Providers are asking about them. And more and more people are using them and showing off their results. And if you’ve spent more than five […]
Popular Posts
About DiversifyRx
DiversifyRx is dedicated to helping pharmacy owners kick a$$. We strongly believe the key to success is diversifying your revenue streams and maximizing each opportunity that is right for you. DiversifyRx was created by pharmacy owners for pharmacy owners. We have experienced a lot of triumphs and disasters and want to share our knowledge with you. This site contains affiliate links to products or services. We may receive a commission for purchases made through these links.